CK Life Sciences Int'l., (Holdings) Inc. 的關鍵財務報表是什麼?
00775.HK 的關鍵財務比率是什麼?
CK Life Sciences Int'l., (Holdings) Inc. 的收入按細分市場或地理位置如何劃分?
CK Life Sciences Int'l., (Holdings) Inc. 是否盈利?
CK Life Sciences Int'l., (Holdings) Inc. 有負債嗎?
CK Life Sciences Int'l., (Holdings) Inc. 的流通股有多少?
關鍵數據
前收市價
$0.84
開盤價
$0.83
當日範圍
$0.83 - $0.84
52週區間
$0.45 - $1.1
交易量
558.0K
平均成交量
5.9M
每股盈餘 (TTM)
-0.03
股息收益率
--
市值
$8.0B
什麼是 CKLIFE SCIENCES?
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. The company employs 1,935 full-time employees The company went IPO on 2002-07-16. The firm is mainly engaged in human health businesses such as research and development, production, promotion and sales of health products and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.